JP2023516067A5 - - Google Patents
Info
- Publication number
- JP2023516067A5 JP2023516067A5 JP2022552528A JP2022552528A JP2023516067A5 JP 2023516067 A5 JP2023516067 A5 JP 2023516067A5 JP 2022552528 A JP2022552528 A JP 2022552528A JP 2022552528 A JP2022552528 A JP 2022552528A JP 2023516067 A5 JP2023516067 A5 JP 2023516067A5
- Authority
- JP
- Japan
- Prior art keywords
- region
- heavy chain
- light chain
- seq
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062984139P | 2020-03-02 | 2020-03-02 | |
| US62/984,139 | 2020-03-02 | ||
| US202063084138P | 2020-09-28 | 2020-09-28 | |
| US63/084,138 | 2020-09-28 | ||
| PCT/US2021/020511 WO2021178430A2 (en) | 2020-03-02 | 2021-03-02 | Chimeric antigen receptors and related methods and compositions for the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023516067A JP2023516067A (ja) | 2023-04-17 |
| JP2023516067A5 true JP2023516067A5 (https=) | 2024-03-06 |
| JP7834345B2 JP7834345B2 (ja) | 2026-03-24 |
Family
ID=77613112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552528A Active JP7834345B2 (ja) | 2020-03-02 | 2021-03-02 | がんの処置のためのキメラ抗原受容体ならびに関連した方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12595311B2 (https=) |
| EP (1) | EP4114861A4 (https=) |
| JP (1) | JP7834345B2 (https=) |
| KR (1) | KR20220149606A (https=) |
| CN (1) | CN115551891A (https=) |
| AU (1) | AU2021232512A1 (https=) |
| CA (1) | CA3174575A1 (https=) |
| WO (1) | WO2021178430A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| WO2025100965A1 (ko) * | 2023-11-07 | 2025-05-15 | 주식회사 박셀바이오 | EphA2를 타겟하는 개선된 특성을 갖는 친수성 모노바디 및 이를 포함하는 다중특이적 키메라 항원 수용체 및 조작된 면역세포 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050037420A1 (en) | 2001-09-14 | 2005-02-17 | Mei-Yun Zhang | Immunoglobulin having particular framework scaffold and methods of making and using |
| US8147832B2 (en) | 2003-08-14 | 2012-04-03 | Merck Patent Gmbh | CD20-binding polypeptide compositions and methods |
| JP7065782B2 (ja) | 2016-03-18 | 2022-05-12 | フレッド ハッチンソン キャンサー リサーチ センター | Ｃｄ２０免疫療法のための組成物および方法 |
| KR20230148844A (ko) | 2016-03-29 | 2023-10-25 | 유니버시티 오브 써던 캘리포니아 | 암을 표적하는 키메라 항원 수용체 |
| ES2981703T3 (es) | 2016-09-02 | 2024-10-10 | Lentigen Tech Inc | Composiciones y métodos para tratar cáncer con DuoCars |
| EP3529268B1 (en) | 2016-10-19 | 2025-02-26 | The Scripps Research Institute | Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof |
| JP7538601B2 (ja) | 2017-04-26 | 2024-08-22 | ユーリカ セラピューティックス， インコーポレイテッド | キメラ活性化受容体及びキメラ刺激受容体を発現する細胞並びにその使用 |
| CA3069527A1 (en) | 2017-07-12 | 2019-01-17 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for treatment of cancers harboring an h3k27m mutation |
| WO2019067805A1 (en) | 2017-09-27 | 2019-04-04 | University Of Southern California | NEW PLATFORMS FOR CO-STIMULATION, NEW CAR DESIGNS AND OTHER IMPROVEMENTS FOR ADOPTIVE CELL THERAPY |
| CN113924103B (zh) * | 2019-03-06 | 2025-02-14 | 莱蒂恩技术公司 | 用于用自驱动的嵌合抗原受体来治疗癌症的组合物和方法 |
| KR20230153529A (ko) | 2021-02-19 | 2023-11-06 | 프리트 엠. 쇼드하리 | 다양한 면역세포를 위한 단일사슬 및 다중사슬 합성 항원 수용체 |
-
2021
- 2021-03-02 US US17/908,703 patent/US12595311B2/en active Active
- 2021-03-02 WO PCT/US2021/020511 patent/WO2021178430A2/en not_active Ceased
- 2021-03-02 CA CA3174575A patent/CA3174575A1/en active Pending
- 2021-03-02 AU AU2021232512A patent/AU2021232512A1/en active Pending
- 2021-03-02 JP JP2022552528A patent/JP7834345B2/ja active Active
- 2021-03-02 CN CN202180032322.2A patent/CN115551891A/zh active Pending
- 2021-03-02 KR KR1020227034525A patent/KR20220149606A/ko active Pending
- 2021-03-02 EP EP21764636.3A patent/EP4114861A4/en active Pending
-
2024
- 2024-10-15 US US18/915,927 patent/US12479923B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI899054B (zh) | 治療癌症及增強ｔ細胞重定向治療劑之功效的方法（一） | |
| CN112673022B (zh) | 针对cd33的单结构域抗体及其构建体 | |
| JP7573441B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| US12534532B2 (en) | CLL1-targeting antibody and application thereof | |
| JP2022002546A (ja) | 細胞 | |
| JP2023516067A5 (https=) | ||
| IL312206A (en) | Preparations and methods for selective protein expression | |
| JP2022548778A5 (https=) | ||
| TW201904997A (zh) | 引導及導航控制蛋白質以及彼之製造及使用方法 | |
| CA3032054A1 (en) | Combination therapies of chimeric antigen receptors and pd-1 inhibitors | |
| CA3131016A1 (en) | Multifunctional molecules that bind to calreticulin and uses thereof | |
| CN116829194A (zh) | 用于工程化细胞疗法的靶向细胞因子构建体 | |
| JP2025066746A (ja) | 抗ａｄａｍ１２抗体およびキメラ抗原受容体、ならびにそれを含む組成物および方法 | |
| WO2022012681A1 (en) | Multispecific chimeric antigen receptors and uses thereof | |
| WO2023202280A1 (zh) | 抗B7H6的scFv抗体、其编码基因及其应用 | |
| JP2024105603A (ja) | ＣＡＲライブラリおよびｓｃＦｖの製造方法 | |
| KR20210111244A (ko) | 태반-유래 동종이계 car-t 세포 및 이의 용도 | |
| WO2023217062A1 (zh) | 一种嵌合抗原受体及其应用 | |
| WO2025140265A1 (en) | Combination of chimeric antigen receptor and dap10 in cell therapy | |
| TW202309294A (zh) | 病毒載體生產系統 | |
| TW202434636A (zh) | 抗原結合域及其使用方法 | |
| CN117957246A (zh) | Mog结合蛋白和其用途 | |
| JP2022546590A5 (https=) | ||
| JP2025540909A (ja) | 免疫療法のためのｃｄ３発現及びキメラ抗原受容体の遮断 | |
| KR20260036568A (ko) | 세포 면역 요법용 조성물, 및 방법 |